Journal
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
Volume 597, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.physa.2022.127258
Keywords
SEIR; COVID-2019; Vaccine; Cellular automata; Stochastic model; Spread disease
Categories
Funding
- Fundacao Araucaria, Brazil
- CNPq, Brazil [407543/2018-0, 302903/2018-6, 420699/2018-0, 407299/2018-1, 428388/2018-3, 311168/2020-5]
- CAPES, Brazil [88887.485425/2020-00]
- Sao Paulo Research Foundation, Brazil [FAPESP 2018/03211-6, 2020/04624-2]
Ask authors/readers for more resources
In this study, we propose the inclusion of two vaccination doses in the SEIR model using a stochastic cellular automaton to support decision making of immunisation strategies. Our results suggest that the number of vaccinations and time to start the vaccination have more impact than vaccine efficacy and delays between doses.
In this work, to support decision making of immunisation strategies, we propose the inclusion of two vaccination doses in the SEIR model considering a stochastic cellular automaton. We analyse three different scenarios of vaccination: (i) unlimited doses, (ii) limited doses into susceptible individuals, and (iii) limited doses randomly distributed overall individuals. Our results suggest that the number of vaccinations and time to start the vaccination is more relevant than the vaccine efficacy, delay between the first and second doses, and delay between vaccinated groups. The scenario (i) shows that the solution can converge early to a disease-free equilibrium for a fraction of individuals vaccinated with the first dose. In the scenario (ii), few two vaccination doses divided into a small number of applications reduce the number of infected people more than into many applications. In addition, there is a low waste of doses for the first application and an increase of the waste in the second dose. The scenario (iii) presents an increase in the waste of doses from the first to second applications more than the scenario (ii). In the scenario (iii), the total of wasted doses increases linearly with the number of applications. Furthermore, the number of effective doses in the application of consecutive groups decays exponentially overtime. (C) 2022 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available